Hydrocortisone reduces the beneficial effects of toll-like receptor 2 deficiency on survival in a mouse model of polymicrobial sepsis

Shock

Volumn 40, Issue 5, 2013, Pages 414-419

  Bergt, Stefan ^a   Wagner, Nana Maria ^a   Heidrich, Manja ^a   Butschkau, Antje ^a   Nöldge Schomburg, Gabriele E F ^a   Vollmar, Brigitte ^a   Roesner, Jan P ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

cecal ligation and puncture; Hydrocortisone; mouse; sepsis and mortality; Toll like receptor 2

Indexed keywords

CORTICOSTERONE; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOTEICHOIC ACID; TOLL LIKE RECEPTOR 2;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; BLOOD CELL COUNT; CECUM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; IMMUNE DEFICIENCY; LACTOBACILLUS GASSERI; LIGATION; LYMPHOCYTE COUNT; MALE; MORTALITY; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PERITONEAL CAVITY; POLYMICROBIAL SEPSIS; POSTOPERATIVE CARE; PREVOTELLA LOESCHEII; PROPIONIBACTERIUM; PROPIONIBACTERIUM PROPIONICUM; PUNCTURE; SEPSIS; SHAM PROCEDURE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS SCIURI; STREPTOCOCCUS; STRESS; SURVIVAL; SURVIVAL RATE; THERAPY EFFECT; TOLL LIKE RECEPTOR 2 DEFICIENCY; WILD TYPE; WOLINELLA;

ANIMALS; CORTICOSTERONE; DISEASE MODELS, ANIMAL; FEEDBACK, PHYSIOLOGICAL; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PITUITARY-ADRENAL SYSTEM; SEPSIS; SPECIES SPECIFICITY; SURVIVAL ANALYSIS; TOLL-LIKE RECEPTOR 2;

EID: 84887039042     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000029     Document Type: Article

References (35)

1. Texereau J, Chiche JD, Taylor W, Choukroun G, Comba B, Mira JP: The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis 41(Suppl 7):S408YS415, 2005.
2. Puliti M, Uematsu S, Akira S, Bistoni F, Tissi L: Toll-like receptor 2 deficiency is associated with enhanced severity of group B streptococcal disease. Infect Immun 77(4):1524-1531, 2009.
3. Echchannaoui H, Frei K, Schnell C, Leib SL, Zimmerli W, Landmann R: Tolllike receptor 2Ydeficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis 186(6):798-806, 2002.
4. Bornstein SR, Zacharowski P, Schumann RR, Barthel A, Tran N, Papewalis C, Rettori V, McCann SM, Schulze-Osthoff K, Scherbaum WA, et al.: Impaired adrenal stress response in Toll-like receptor 2Ydeficient mice. Proc Natl Acad Sci USA 101(47):16695-16700, 2004.
5. Pabst S, Yenice V, Lennarz M, Tuleta I, Nickenig G, Gillissen A, Grohe C: Toll-like receptor 2 gene polymorphisms Arg677Trp and Arg753Gln in chronic obstructive pulmonary disease. Lung 187(3):173-178, 2009.
6. Schroder NW, Hermann C, Hamann L, Gobel UB, Hartung T, Schumann RR: High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med (Berl) 81(6): 368-372, 2003.
7. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, et al.: CORTICUS Study Group: Hy-drocortisone therapy for patients with septic shock. N Engl J Med 358(2): 111-124, 2008.
8. Christaki E, Opal SM: Is the mortality rate for septic shock really decreasing? Curr Opin Crit Care 14(5):580-586, 2008.
9. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al.: Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41(2):580-637, 2013.
10. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shockVa review of laboratory models and a proposal. J Surg Res 29(2):189-201, 1980.
11. Nolan A, Weiden MD, Thurston G, Gold JA: Vascular endothelial growth factor blockade reduces plasma cytokines in a murine model of polymicrobial sepsis. Inflammation 28(5):271-278, 2004.
12. Pinkerton WM: A method of injecting small laboratory animals by the ophthalmic plexus route. Proc Soc Exp Biol Med 116:429-432, 1964.
13. Lever A, Mackenzie I: Sepsis: definition, epidemiology, and diagnosis. BMJ 335(7625):879-883, 2007.
14. Selye H: A syndrome produced by diverse nocuous agents. Nature 38:32, 1936.
15. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332(20):1351-1362, 1995.
16. de Jong MF, Beishuizen A, Spijkstra JJ, Groeneveld AB: Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock. Crit Care Med 35(8):1896-1903, 2007.
17. Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P: Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 174(12):1319-1326, 2006.
18. Mesotten D, Vanhorebeek I, Van den Berghe G: The altered adrenal axis and treatment with glucocorticoids during critical illness. Nat Clin Pract Endocrinol Metab 4(9):496-505, 2008.
19. Marik PE: Critical illnessYrelated corticosteroid insufficiency. Chest 135(1): 181-193, 2009.
20. Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al-Abdulkareem A, Knawy BA, Hajeer AH, Tamimi W, Cherfan A: Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ 182(18):1971-1977, 2010.
21. Hamrahian AH, Oseni TS, Arafah BM: Measurements of serum free cortisol in critically ill patients. N Engl J Med 350(16):1629-1638, 2004.
22. Bornstein SR, Ziegler CG, Krug AW, Kanczkowski W, Rettori V, McCann SM, Wirth M, Zacharowski K: The role of Toll-like receptors in the immune-adrenal crosstalk. Ann N Y Acad Sci 1088:307-318, 2006.
23. Kanczkowski W, Zacharowski K, Bornstein SR: Role of Toll-like receptors and inflammation in adrenal gland insufficiency. Neuroimmunomodulation 17(3):180-183, 2010.
24. Tsujimoto H, Ono S, Efron PA, Scumpia PO, Moldawer LL, Mochizuki H: Role of Toll-like receptors in the development of sepsis. Shock 29(3): 315-321, 2008.
25. Gekara NO, Dietrich N, Lyszkiewicz M, Lienenklaus S, Weiss S: Signals triggered by a bacterial pore-forming toxin contribute to Toll-like receptor redundancy in gram-positive bacterial recognition. J Infect Dis 199(1):124-133, 2009.
26. Remick DG, Bolgos G, Copeland S, Siddiqui J: Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun 73(5):2751-2757, 2005.
27. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 24(Suppl 1):52-57, 2005.
28. Dyson A, Singer M: Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med 37(Suppl 1): S30YS37, 2009.
29. Misch EA, Hawn TR: Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci (Lond) 114(5):347-360, 2008.
30. Lee SO, Brown RA, Kang SH, Abdel-Massih RC, Razonable RR: Toll-like receptor 2 polymorphism and gram-positive bacterial infections after liver transplantation. Liver Transpl 17(9):1081-1088, 2011.
31. Alves-Filho JC, Freitas A, Souto FO, Spiller F, Paula-Neto H, Silva JS, Gazzinelli RT, Teixeira MM, Ferreira SH, Cunha FQ: Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci USA 106(10):4018-4023, 2009.
32. Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM, Woodruff TM: Toll-like receptors in ischemia-reperfusion injury. Shock 32(1):4-16, 2009.
33. Ehrentraut SF, Dorr A, Ehrentraut H, Lohner R, Lee SH, Hoeft A, Baumgarten G, Knuefermann P, Boehm O, Meyer R: Vascular dysfunction following polymicrobial sepsis: role of pattern recognition receptors. PLoS One 7(9): e44531, 2012.
34. Russell JA: Management of sepsis. N Engl J Med 355(16):1699-1713, 2006.
35. Panomket P, Chetchotisakd P, Sermswan RW, Pannengpetch P, Wongratanacheewin S: Use of a low-dose steroid as an adjunct in the treatment, in mice, of severe sepsis caused by Burkholderia pseudomallei. Ann Trop Med Parasitol 103(7): 635-646, 2009.